Kara
Специализация
Kara Murphy is a partner in Bain & Company's Boston office. She has worked at Bain since 2000.
She is a member of Bain's Private Equity and Healthcare practices and co-leads the firm's healthcare private equity team.
Kara has led more than 175 healthcare private equity diligences and has worked extensively with private-equity backed portfolio companies. Her private equity work spans the healthcare value chain of med tech, pharma, providers, payers, services and IT.
Kara also has worked with corporate clients across the healthcare value chain on issues ranging from M&A to growth strategy to performance improvement.
Kara earned her MBA from Harvard Business School. She is also a graduate of Tufts University, where she received a Bachelor of Science in Mathematics and Quantitative Economics.
Kara Murphy discusses how private equity and corporate investors can evaluate business opportunities and risks that these trends create.
Recent Insights
- “Healthcare as National Defense,” Dry Powder: The Private Equity Podcast, 05.05.2021 , Podcast
- “Healthcare Heroics,” Dry Powder: The Private Equity Podcast, 28.04.2021 , Podcast
- “Deals Roll On: Healthcare Private Equity Withstands the Pandemic’s Rout,” Infographic, 20.04.2021
- “Welcome Letter: Fertile Conditions for Healthcare Private Equity Investment,” Report, 17.03.2021
- “Healthcare Private Equity Market 2020: The Year in Review,” Report, 17.03.2021
In the News
- “Healthcare private equity buyouts posted record-setting volumes in 2020 after a year of unprecedented upheaval for global healthcare,” Press release, 16.03.2021
- “HCIT M&A in the wake of COVID-19; Blackstone goes shopping,” PE Hub, 12.03.2020 , Здравоохранение
- “Column: Bain's Kara Murphy on the Amazon Effect, provider deal flow ,” Buyouts, 18.04.2018 , Здравоохранение
- “Early Move Into Behavioral Health Leads to 12-Times Return for Waud,” WSJ Pro, 27.03.2018 , Прямые инвестиции
- “Back to School: Bar rises for healthcare investors,” Buyouts, 01.05.2017 , Здравоохранение